(Q52109699)

22 April 2018

title

Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease. (English)

1 reference

22 April 2018

1 reference

Harrell LE

1

1 reference

22 April 2018

Jope RS

2

1 reference

22 April 2018

Falgout J

3

1 reference

22 April 2018

Callaway R

4

1 reference

22 April 2018

Avery C

5

1 reference

22 April 2018

Spiers M

6

1 reference

22 April 2018

Leli D

7

1 reference

22 April 2018

Morere D

8

1 reference

22 April 2018

Halsey JH Jr

9

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 February 1990

1 reference

22 April 2018

Journal of the American Geriatrics Society

published in

1 reference

22 April 2018

volume

38

1 reference

22 April 2018

issue

2

1 reference

22 April 2018

page(s)

113-122

1 reference

22 April 2018

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Oral physostigmine treatment of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Oral physostigmine and lecithin improve memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Effects of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Physostigmine effects in Alzheimer's disease: relationship to dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

A new and rapid colorimetric determination of acetylcholinesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Selective reminding test: an examination of the equivalence of four forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Elevated red blood cell/plasma choline ratio in dementia of the Alzheimer type: clinical and polysomnographic correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Tetrahydroaminoacridine, 3,4 diaminopyridine and physostigmine: direct comparison of effects on memory in aged primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Differential responsivity of verbal and visual recognition memory to physostigmine and ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB03471.X

10.1111/J.1532-5415.1990.TB03471.X

21 January 2018

Identifiers

DOI

1 reference

22 April 2018

PubMed ID

2405043

1 reference

22 April 2018